Cargando…

Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs

IMPORTANCE: Previous studies have found that hospitals participating in the 340B Drug Pricing Program have higher Medicare Part B spending and expansion into affluent neighborhoods. Less is known about the association of 340B participation with spending by commercial insurance, where reimbursements...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Jessica, Karaca-Mandic, Pinar, Nikpay, Sayeh, Jeffery, Molly Moore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290244/ https://www.ncbi.nlm.nih.gov/pubmed/37351874 http://dx.doi.org/10.1001/jamahealthforum.2023.1485

Ejemplares similares

Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016
por: Conti, Rena M., et al.
Publicado: (2019)

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Association of Beneficiary-Level Risk Factors and Hospital-Level Characteristics With Medicare Part B Drug Spending Differences Between 340B and Non-340B Hospitals
por: Li, Yufei, et al.
Publicado: (2022)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Association of Participation in a Value-Based Insurance Design Program With Health Care Spending and Utilization
por: Zhang, Hui, et al.
Publicado: (2023)

Breadth and Exclusivity of Hospital and Physician Networks in US Insurance Markets
por: Graves, John A., et al.
Publicado: (2020)

Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factors
por: Togun, Adeniyi T., et al.
Publicado: (2021)

Geographic Variation in Hospital-Based Physician Participation in Insurance Networks
por: Nikpay, Sayeh, et al.
Publicado: (2022)

Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma
por: Jazowski, Shelley A., et al.
Publicado: (2022)

Interfacility Transfer of Uninsured vs Insured Patients With ST-Segment Elevation Myocardial Infarction in California
por: Ward, Michael J., et al.
Publicado: (2023)

Trends in 340B Drug Pricing Program Contract Growth Among Retail Pharmacies From 2009 to 2022
por: Nikpay, Sayeh, et al.
Publicado: (2023)

Comparison of Postpartum Health Care Use and Spending Among Individuals with Medicaid-Paid Births Enrolled in Continuous Medicaid vs Commercial Insurance
por: Gordon, Sarah H., et al.
Publicado: (2022)

Downstream Mammary and Extramammary Cascade Services and Spending Following Screening Breast Magnetic Resonance Imaging vs Mammography Among Commercially Insured Women
por: Ganguli, Ishani, et al.
Publicado: (2022)

Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 2016
por: Jeffery, Molly M., et al.
Publicado: (2019)

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Utilization and Spending on Mental Health Services Among Children and Youths With Commercial Insurance
por: Kalmin, Mariah M., et al.
Publicado: (2023)

Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018
por: Fang, Hanming, et al.
Publicado: (2022)

Geographical Variation in Health Spending Across the US Among Privately Insured Individuals and Enrollees in Medicaid and Medicare
por: Cooper, Zack, et al.
Publicado: (2022)

Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
por: Follman, Sarah, et al.
Publicado: (2019)

Medicare and Private Insurance Variations in New Medical Technology: The Case of Drug Eluting Stents
por: Bayindir, Esra Eren, et al.
Publicado: (2016)

Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018
por: Alpern, Jonathan D., et al.
Publicado: (2022)

HIV Testing among Outpatients with Medicaid and Commercial Insurance
por: Dietz, Patricia M., et al.
Publicado: (2015)

Characteristics of Hydroxychloroquine Dispensing in the United States, January to May 2020
por: Levin, Zachary, et al.
Publicado: (2021)

Outcomes of the 340B Drug Pricing Program: A Scoping Review
por: Knox, Ryan P., et al.
Publicado: (2023)

Estimates of healthcare spending for preterm and low-birthweight infants in a commercially insured population: 2008–2016
por: Beam, Andrew L., et al.
Publicado: (2020)

Decomposition of outpatient health care spending by disease - a novel approach using insurance claims data
por: Stucki, Michael, et al.
Publicado: (2021)

Microeconomic Costs, Insurance, and Catastrophic Health Spending Among Patients With Acute Myocardial Infarction in India: Substudy of a Randomized Clinical Trial
por: Mohanan, Padinhare P., et al.
Publicado: (2019)

US Trends in COVID-19–Associated Hospitalization and Mortality Rates Before and After Reopening Economies
por: Gupta, Sumedha, et al.
Publicado: (2021)

Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
por: Jena, Anupam B, et al.
Publicado: (2014)

Trends in Social Spending by Private Health Insurers
por: Velasquez, David E., et al.
Publicado: (2022)

Spending and Out-of-Pocket Prices for Brand-Name Drugs Among Commercially Insured Individuals in Massachusetts, 2015-2017
por: Aaron, Micah B., et al.
Publicado: (2021)

Consistency and Adequacy of Public and Commercial Health Insurance for US Children, 2016 to 2021
por: Daw, Jamie R., et al.
Publicado: (2023)

Assessment of Oncology Advanced Practice Professional Willingness to Participate in Medical Aid in Dying
por: Singer, Jonathan, et al.
Publicado: (2022)

Assessment of Dentist Participation in Public Insurance Programs for Children in the US
por: Serban, Nicoleta, et al.
Publicado: (2022)

Patient Participation in Clinical Trials of Oncology Drugs and Biologics Preceding Approval by the US Food and Drug Administration
por: Hutchinson, Nora, et al.
Publicado: (2021)

Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020
por: Dickson, Sean, et al.
Publicado: (2023)

Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices
por: Togun, Adeniyi T, et al.
Publicado: (2021)

Assessment of Spending for Patients Initiating Dialysis Care
por: League, Riley J., et al.
Publicado: (2022)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gme28onkl6qhdlvan2mt331f6b